...
首页> 外文期刊>Neurochemical journal >Protective Effects of G Protein-Coupled Estrogen Receptor 1 (GPER1) on β-Amyloid-Induced Neurotoxicity: Implications for Alzheimer’s Disease
【24h】

Protective Effects of G Protein-Coupled Estrogen Receptor 1 (GPER1) on β-Amyloid-Induced Neurotoxicity: Implications for Alzheimer’s Disease

机译:G蛋白偶联雌激素受体1(GPER1)对β-淀粉样蛋白诱导的神经毒性的保护作用:对阿尔茨海默病的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Alzheimer’s disease (AD) is a problematic disease that has shown a significant increase in patient numbers worldwide. AD is identified pathologically by the accumulation of the toxic amyloid beta (Aβ) protein, neurofibrillary tangles and neuropil threads in postmortem brains of AD patients. Women are more prone to AD either due to their increased life expectancy or the decline in Estrogen hormone levels around menopause. Estrogens play a physiologically important role in the brain, but there is debate about the association between estrogen and Ad. The neuroprotective effects of estrogens are possibly mediated by estrogen receptors (ERs), which include classical nuclear estrogen receptors (ERα and ERβ) and nonclassical ER (G protein-coupled estrogen receptor 1, GPER1(GPR30)). The effect of GPER1 on Aβ-induced neurotoxicity is unclear. Here we studied the effect of GPER1 receptor agonists G-1 on rat neuronal cells. Rat neuronal cells were incubated with Aβ1–42, either alone or in combination with GPER1 agonist G-1 (10?7, 10?8 and 10?9 M). Cell viability was determined by MTT assays and apoptotic effects induced by Aβ1–42 were measured by Cell Death Detection kit. Oxidative stress parameters, including nitric oxide (NO) levels and total oxidant status (TOS) were measured by spectrophotometry. Approximately half of the cell death was observed with 10?6 M Aβ1–42 incubation for 48 hours. This is the first study that explores the effect of activation of GPER1 by its agonist G-1 on neuroprotection against Aβ1–42-toxicity in rat neuronal cells. GPER1 activation significantly reduced on rat neuronal cells. Aβ1–42 induced cell death was significantly reduced by co-incubating with G-1. Our results suggest that G-1 treatment protects neurons from Aβ1–42 induced neurotoxicity by changing the oxidative parameters on rat neuronal cells.
机译:阿尔茨海默病的疾病(AD)是一个有问题的疾病,它显示了全球患者数字的显着增加。通过毒性淀粉样蛋白β(Aβ)蛋白,神经纤维斑末端和神经覆盖物在AD患者的后期大脑中的积累来识别AD。由于他们的预期寿命增加或更年期周围的雌激素激素水平的下降,女性更容易发生广告。雌激素在大脑中发挥生理上重要作用,但是关于雌激素和广告之间的关联存在争论。雌激素的神经保护作用可能由雌激素受体(ER)介导,包括经典核雌激素受体(ERα和ERβ)和非生物体ER(G蛋白偶联雌激素受体1,GPER1(GPR30))。 GPER1对Aβ诱导的神经毒性的影响尚不清楚。在这里,我们研究了GPER1受体激动剂G-1对大鼠神经元细胞的影响。将大鼠神经元细胞与Aβ1-42一起孵育,或与GPER1激动剂G-1(10→7,10→8和10→9μl组合。通过MTT测定法测定细胞活力,通过细胞死亡检测试剂盒测量由Aβ1-42诱导的凋亡效应。通过分光光度法测量氧化应激参数,包括一氧化氮(NO)水平和总氧化剂状态(TOS)。观察到大约一半的细胞死亡,用10?6MAβ1-42孵育48小时。这是第一项研究,探讨GPER1激活对大鼠神经元细胞Aβ1-42毒性的神经保护作用的激活效果。 GPER1激活在大鼠神经元细胞上显着降低。通过与G-1共孵育,Aβ1-42诱导细胞死亡显着降低。我们的研究结果表明,G-1处理通过改变大鼠神经元细胞上的氧化参数来保护来自Aβ1-42诱导的神经毒性的神经元。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号